Official journal for @my_UEG, publishing high quality research in gastroenterology, hepatology and related fields. Free open access. NEW Impact factor: 6.7
🩸Persistent thrombocytopenia predicts mortality after #LiverTransplantation
🔸 #PortalHypertension persisted in 55% at 1 year
🔸PH-related events occurred in 11.6%
🔸Platelets <110 G/L at 3 months linked to 2.31× higher mortality
📖 #OpenAccess 👉 https://t.co/dEiUt5DTqU
💼 #FunctionalDyspepsia carries a substantial economic burden
🔸Mean annual costs: €12,192 per patient
🔸84% from productivity losses
🔸Poorer disease-specific #QoL linked to higher costs
🔸Symptom severity was not linked to costs
📖 #OpenAccess 👉 https://t.co/HeANzuWtMt
🌍 #DGBI is associated with a high burden of alarm features
🔸75% of <50y with DGBI reported alarm features vs 51% without
🔸68% of ≥50y with DGBI vs 39% without
🔸Multiple alarm features were also more common in DGBI
📖 #OpenAccess 👉 https://t.co/ThhF9UEzX7
@my_ueg
🧪Baseline serum #albumin (SA) predicts benefit from long-term albumin in #Cirrhosis
🔸18month survival improved when SA≤3.2 g/dL
🔸No survival benefit shown with SA>3.2 g/dL
🔸Fewer complications & hospitalizations across levels
📖 #OpenAccess 👉 https://t.co/rhXoOlm9ot
🫀 Metabolic syndrome identifies a high-risk phenotype in #IBD
🔸Cardiometabolic comorbidities increased over time
🔸Higher cardiovascular, kidney & liver risks
🔸More hospitalizations, steroid use & surgery
📖 #OpenAccess 👉 https://t.co/rSdpB5IKBG
@my_ueg
💊 Acid-suppressive therapy is associated with more frequent symptoms in #FunctionalDyspepsia
🔸60% of patients received acid suppression
🔸More early satiation, nausea & epigastric pain
🔸Persistent symptoms may warrant reassessment
📖 #OpenAccess 👉 https://t.co/fGXidGjUKO
New @UEGJournal Podcast episode is out! 🎧
Tune in as our hosts @MohsenSubhani and @MMEstevinho explore the metabolic and systemic links behind GI diseases.
🔗 https://t.co/7LowOV4Lp8
🧩 Self-reported #GlutenSensitivity may go beyond gluten
🔸14.2% of adults reported NCGS
🔸69.4% also had a DGBI and/or ARFID symptoms
🔸24% had NCGS + DGBI + ARFID symptoms
🔸Multiple non-gluten food intolerances were common
📖 #OpenAccess 👉 https://t.co/SElnEk7lLS